Moleculera Labs, founded with a mission to transform medical care through precision medicine, focuses on uncovering immune-mediated root causes of chronic central nervous system (CNS) and cardiovascular disorders. The company offers clinical testing services for neurologic conditions such as motor tics, obsessive-compulsive disorders (OCD), and sometimes Autism Spectrum Disorders. By providing objective testing results, Moleculera Labs aims to enable physicians to treat the underlying causes rather than just the symptoms.
Notable affiliated individuals include leading researchers and clinicians in the fields of neurology and immunology. Key achievements include the development of advanced diagnostic tests that have significantly impacted the understanding and treatment of complex CNS disorders. Moleculera Labs has made a substantial impact by reshaping the approach to diagnosing and treating chronic neurological conditions, thereby improving patient outcomes and advancing the field of precision medicine.
